Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03404518 · ClinicalTrials.gov registry record · Phase 3
Patient Narcotic Requirements After Outpatient Otolaryngology Procedures
A Phase 3 study, sponsored by Loma Linda University.
- Completed
- Registry status
- Phase 3
- Development phase
- 185
- Enrollment target
NCT03404518 is a Phase 3 study that has completed, run by Loma Linda University. The registered enrollment target is 185 participants.
The verdict
NCT03404518, a Phase 3 study, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 185 participants
- Enrollment target
Study Summary
Patient's pain level and narcotic requirements will be evaluated after routine outpatient Otolaryngology procedures. This will be done by having study participants record their pain level and medication usage from home.
Interventions
- DRUG Ibuprofen
- DRUG Norco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 185 participants |
| Start Date | 2018-02-21 |
| Est. Completion | 2018-10-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03404518
The ClinicalTrials.gov registry entry for NCT03404518 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 185 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ibuprofen is the first listed.
NCT03404518 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03404518 about?
NCT03404518 is a clinical study titled "Patient Narcotic Requirements After Outpatient Otolaryngology Procedures". Patient's pain level and narcotic requirements will be evaluated after routine outpatient Otolaryngology procedures. This will be done by having study participants record their pain level and medication usage from home.
What is the current status of trial NCT03404518?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 185 participants. The study started on 2018-02-21. Estimated completion is 2018-10-01.
What interventions are being tested in trial NCT03404518?
The interventions under investigation include: Ibuprofen (DRUG), Norco (DRUG).
Who is sponsoring clinical trial NCT03404518?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.